Results 31 to 40 of about 522,058 (284)

What's in a Word? Falsified/Counterfeit/Fake Medicines - The Definitions Debate

Medicine Access @ Point of Care, 2017
There is a rising tide of criminal activity to manufacture and distribute falsified, counterfeit, or fake medicines. The exact size of this problem is unknown but estimates vary from US$75 billion to US$200 billion per year, and evidence clearly ...
Mike Isles
doaj   +1 more source

Health-industry linkages for local health: reframing policies for African health system strengthening [PDF]

, 2018
The benefits of local production of pharmaceuticals in Africa for local access to medicines and to effective treatment remain contested. There is scepticism among health systems experts internationally that production of pharmaceuticals in sub-Saharan ...
ACT Watch Group, African Union, African Union, African Union, African Union, Aldis, Battams, Berger, Bigdeli, Boschma, Chataway, Chaudhuri, Cohen, Commission on Social Determinants of Health (CSDH), Dinh, East African Community (EAC), Eriksen, Ernst, Ewen, Federal Democratic Republic of Ethiopia (FDRE), Flahault, Gebre-Mariam, Geoffrey Banda, Giddens, Government of Kenya, Government of Uganda, Hahn, Horton, Institute for Health Metrics and Evaluation (IHME), Jires Tunguhole, Julius Mugwagwa, Kaplan, Kaplan, Koplan, Kumar, Lin, Lopes, Macfarlane, Mackintosh, Mackintosh, Mackintosh, Malmberg, Maureen Mackintosh, Mercy Karimi Njeru, Ministry of Industry (MIT) and UNIDO, Morris, Mujinja, Nadvi, Ozawa, Paula Tibandebage, Ravix, Republic of Ghana, Republic of Kenya, Rowson, Rushton, Samuel Wangwe, Schmitz, Seiter, Shadlen, Sheikh, Shiffman, Sidibé, Srinivas, Sutton, UNCTAD, United Nations (UN), United Republic of Tanzania (URT), United Republic of Tanzania (URT), Waako, Wagner, West, WHO/World Bank, Wiedenmayer, Wilson, Wirtz, World Health Organisation (WHO), World Health Organisation (WHO), World Health Organisation (WHO), World Health Organisation (WHO), World Health Organisation (WHO), Yadav, Yadav   +81 more
core   +3 more sources

The International Right to Health: What Does It Mean in Legal Practice and How Can It Affect Priority Setting for Universal Health Coverage? [PDF]

, 2015
The international right to health is enshrined in national and international law. In a growing number of cases, individuals denied access to high-cost medicines and technologies under universal coverage systems have turned to the courts to challenge the ...
Chalkidou, Kalipso, Cubillos, Leonardo, Dittrich, Rebecca, Gostin, Lawrence O., Li, Ryan   +4 more
core   +2 more sources

The timelines for the price and reimbursement authorization in Italy 2018–2020

Frontiers in Medicine, 2022
ObjectiveThis investigation aimed to guarantee the principles of transparency in public administration; to inform citizens about the time to patient access to reimbursed medicines; to assess the duration of the P&R process for the first time in the ...
Valentina Gallo, Eva Alessi, Simona Montilla, Gianluca Altamura, Giuseppe Traversa, Francesco Trotta   +5 more
doaj   +1 more source

Access to Medicines and European Market Integration [PDF]

, 2016
In this paper we document a process of price convergence in the European market for pharmaceuticals and relate it to access to innovative medicines in individual countries.
Pammolli, Fabio, Rungi, Armando
core   +1 more source

Access to licenced vaccines for high-threat infectious diseases: a scoping review and interpretive analysis of Ebola virus disease

BMC Infectious Diseases
Background Outbreaks of high-threat zoonotic diseases like Ebola virus disease (EVD) occur more frequently, causing severe health and socioeconomic impacts.
Charlot Diepvens, Donovan Guttieres, Kim De Boeck, Nico Vandaele, Leonor Guariguata, Catherine Decouttere   +5 more
doaj   +1 more source

The potential for deprescribing in care home residents with Type 2 diabetes [PDF]

, 2016
Background: Type 2 diabetes is a common diagnosis in care home residents that is associated with potentially inappropriate prescribing and thus risk of additional suffering.
Andreassen, Lillan Mo, Desborough, James Antony, Houghton, Julie, Kjome, Reidun Lisbet Skeide, Sølvik, Una Ørvim   +4 more
core   +1 more source

A Quality Improvement Initiative to Standardize Pneumocystis jirovecii Pneumonia Prophylaxis in Pediatric Patients With Solid Tumors

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Pediatric patients with extracranial solid tumors (ST) receiving chemotherapy are at an increased risk for Pneumocystis jirovecii pneumonia (PJP). However, evidence guiding prophylaxis practices in this population is limited. A PJP‐related fatality at our institution highlighted inconsistent prescribing approaches and concerns about
Kriti Kumar, Denise M. Connolly, Ellen Kellington, Elyse Zelunka, Karla Kerrigan, Furqan Shaikh, Paul C. Nathan, Meredith S. Irwin, Sarah Cohen‐Gogo   +8 more
wiley   +1 more source

Perspectives on systematic capacity building in pharmaceutical regulation for regulators of medical products

Frontiers in Medicine
Having a robust, integrated regulatory system is important for ensuring the availability of safe and efficacious medical products of good quality and for protecting public health.
Luther Gwaza, Andrew Chemwolo, Mario Musonda, Rutendo Kuwana, Admire Dube   +4 more
doaj   +1 more source

Sickle Cell Disease Is an Inherent Risk for Asthma in a Sibling Comparison Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Sickle cell disease (SCD) and asthma share a complex relationship. Although estimates vary, asthma prevalence in children with SCD is believed to be comparable to or higher than the general population. Determining whether SCD confers an increased risk for asthma remains challenging due to overlapping symptoms and the ...
Suhei C. Zuleta De Bernardis, Okeleji Olayinka, Mariam Z. Quraishi, Lakshmi V. Srivaths, Deborah L. Brown, Neethu M. Menon, Ricardo A. Mosquera, Ashwin P. Patel, James M. Stark, Aravind Yadav   +9 more
wiley   +1 more source